CAT No: CP25488
CAS No:181227-48-5
Synonyms/Alias:Boc-D-Igl-OH;181227-48-5;AmbotzBAA1343;Boc-d-(2-inda)gly-oh;SCHEMBL1598690;CTK8F0531;MolPort-002-345-299;VCHHRDDQOOBPTC-CYBMUJFWSA-N;ZINC2567264;AKOS025312271;RTR-008328;TR-008328;FT-0679742;V3911;(2R)-[(tert-butoxycarbonyl)amino](2,3-dihydro-1H-inden-2-yl)ethanoicacid;(2R)-[(tert-butoxycarbonyl)amino](2,3dihydro-1H-inden-2-yl)ethanoicacid;(R)-[(tert-butoxycarbonyl)amino](2,3-dihydro-1H-inden-2-yl)aceticacid;(2R)-2,3-dihydro-1H-inden-2-yl({[(1,1-dimethylethyl)-oxy]carbonyl}amino)ethanoicacid;(2R)-2,3-Dihydro-1H-inden-2-yl({[(1,1-dimethylethyl)oxy]-carbonyl}amino)ethanoicacid;(2R)-2,3-dihydro-1H-inden-2-yl({[(1,1-dimethylethyl)oxy]carbonyl}-amino)-ethanoicacid;(2R)-2,3-dihydro-1H-inden-2-yl({[(1,1-dimethylethyl)oxy]carbonyl}-amino)ethanoicacid;(2R)-2,3-Dihydro-1H-inden-2-yl({[(1,1-dimethylethyl)oxy]carbonyl}amino)ethanoicacid;(R)-2-(tert-butyloxycarbonylamino)-2-(2,3-dihydro-1H-inden-2-yl)aceticacid
Chemical Name:N-alpha-t-Butyloxycarbonyl-2-indanyl-D-glycine, (R)-2-(t-Butyloxycarbonylamino)-2-(2,3-dihydro-1H-inden-2-yl)acetic acid
2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.